Amphastar Pharmaceuticals prices IPO at $7, below the range

By
A A A

Amphastar Pharmaceuticals, which produces difficult-to-manufacture injectable and inhalable drugs, raised $56 million by offering 8.0 million shares at $7, below the range of $10 to $12. Amphastar Pharmaceuticals plans to list on the NASDAQ under the symbol AMPH. Amphastar Pharmaceuticals initially filed confidentially on 12/16/2013. Jefferies & Co., BMO Capital Markets and Piper Jaffray acted as lead managers on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: AMPH

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

Most Active by Volume

106,679,460
  • $17.03 ▲ 0.47%
101,357,777
  • $38.65 ▼ 5.57%
61,830,117
  • $89.89 ▼ 4.26%
54,116,071
  • $5.11 ▼ 4.49%
50,121,934
  • $101.06 ▲ 0.10%
49,993,927
  • $3.52 ▼ 1.40%
47,717,687
  • $11.44 ▼ 4.67%
44,793,169
  • $99.05 ▼ 0.93%
As of 9/22/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com